Skip to main content
SpringerLink
Log in

The Place of Hormone Receptors in the Elaboration of a Therapeutic stategy Against Breast Cancer

  • Chapter
Book cover Clinical Interest of Steroid Hormone Receptors in Breast Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 91))

  • 112 Accesses

Abstract

When considering the place of hormone receptors in a therapeutic strategy against breast cancer, one must be take into account not only our knowledge of the molecular physiology of hormone-dependent tumors or of their clinical aspects but also the numerous questions concerning these receptors which are still unanswered. These various aspects are dealt with below.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anonymous (1982) Compilation of experimental cancer therapy protocol summaries, 6th ed. US Department of Health and Human Services, Washington, DC

    Google Scholar 

  2. Baulieu EE (1975) Some aspects of the mechanism of action of steroid hormone. Mol Cell Biochem 7: 157–175

    Article  PubMed  CAS  Google Scholar 

  3. Bonadonna G, Valagussa P, Rossi A et al. (1979) CMF adjuvant chemotherapy in operable breast cancer. In: Jones SE, Salmon S (eds) Adjuvant therapy of cancer II. Grune and Stratton, New York, pp 215–226

    Google Scholar 

  4. Buzdar A, Smith T, Blumenshein G, Hortobagyi G, Hersh E, Gehan E (1981) Adjuvant chemotherapy with fluorouracil, doxorubicin and cyclophosphamide (FAC) for stage II or III breast cancer: 5 year results. In: Salmon E, Jones SE (eds) Adjuvant therapy of cancer III. Grune and Stratton, New York, pp 419–426

    Google Scholar 

  5. Cooke T, George D, Shields R, Maynard P, Griffith K (1979) Estrogen receptor and prognosis in early breast cancer. Lancet 1: 1995–1997

    Google Scholar 

  6. Fisher B, Redmond C, participating NSABP investigators (1979) Breast cancer studies on the rational surgical adjuvant breast and colon project (NSABP). In: Jones SE, Salmon S (eds) Adjuvant therapy of cancer II. Grune and Stratton, New York, pp 215–226

    Google Scholar 

  7. Horwitz KB, McGuire WL (1978) Estrogen control of progesterone receptor in human breast cancer. J Biol Chem 253: 2223–2228

    PubMed  CAS  Google Scholar 

  8. Jensen EV, Polluy TZ, Smith S, Block EG, Ferguson DJ, Desombre ER (1975) Prediction of hormone dependence in human breast cancer. In: McGuire WL (ed) Estrogen receptors in human breast cancer. Raven, New York, pp 37–56

    Google Scholar 

  9. Kiang DT, Frenning DH, Goldman AI, Ascensao VF, Kennedy BJ (1978) Estrogen receptors and response to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med 299: 1330–1335

    Article  PubMed  CAS  Google Scholar 

  10. Legha SS, Buzdar AV, Smith TL, Swenerton KD, Hortobagyi GN, Blumenschein GR (1980) Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy. Cancer 46: 438–445

    Article  PubMed  CAS  Google Scholar 

  11. Lippman ME, Cassidy J, Wesley M, Young RC (1982) A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization. In: ASCO Conf, Abstract 79, C-305

    Google Scholar 

  12. Magdelénat H, Pouillart P, Jouve M et al. (1982) Progesterone receptor as a more reliable prognostic parameter than estrogen receptor in patients with advanced breast cancer. Breast Cancer Res Treat 2, 195–196

    Article  PubMed  Google Scholar 

  13. Magdelénat H, Toubeau M, Picco C, Bidron C (1980) Détermination des récepteurs d’oestrogènes et de progestérone sur foragebiopsies des tumeurs mammaires. In: Martin PM (ed) Récepteurs hormonaux et pathologie mammaire. MEDSI, Paris, pp 107–119

    Google Scholar 

  14. Magdelénat H (1979) Simultaneous determination of estrogen and progestin receptors on small amounts of breast tumor cytosols. Cancer Treat Rep 63: 1146

    Google Scholar 

  15. Martin PM, Rolland PH, Jacquemier J, Rolland AM, Toga M (1978) Tumeurs mammaires humaines: corrélation entre les récepteurs hormonaux stéroidiens et l’anatomie pathologie. Bull Cancer (Paris) 65: 383–388

    CAS  Google Scholar 

  16. Martin PM, Benyahia B, Magdelénat H (1982) A new approach for the visualization of estrogen receptors in target tissues: use of autofluorescent ligands and image intensifier. 6th International congress on hormonal steroids, Jerusalem

    Google Scholar 

  17. McGuire WL, Horwitz KB, Pearson OH, Segaloff A (1977) Current status of estrogen and progesterone receptors in breast cancer. Cancer 39: 2934–2947

    Article  PubMed  CAS  Google Scholar 

  18. McGuire WL, Horwitz KB (1978) Progesterone receptors in breast cancer. In: McGuire WL (ed) Hormones, receptors and breast cancer. Raven, New York, pp 31–42

    Google Scholar 

  19. Mauriac L, Wafñart J, Durand M et al. (1981) Apport de la drill-biopsie dans le bilan préthérapeutique des adénocarcinomes mammaires. Bull Cancer (Paris) 68: 417–421

    CAS  Google Scholar 

  20. Meyer JS, Rao BR, Stevens SC (1977) Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer 40: 2290–2298

    Article  PubMed  CAS  Google Scholar 

  21. Namer M, Lalanne C, Baulieu EE (1980) Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer. Cancer Res 40: 1750–1752

    PubMed  CAS  Google Scholar 

  22. Pichón MF, Pallud C, Brunet M, Milgrom E (1980) Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 40: 3357–3360

    PubMed  Google Scholar 

  23. Pouillart P, Palangie T, Jouve M, Garcia-Giralt E, Asselain B, Magdelénat H (1981) Metastatic breast cancer treated simultaneously by cytotoxic chemotherapy and hormonal therapy. Preliminary results of a randomized trial. Review on Endocrine-Related Cancers (Suppl) Oct: 439–453

    Google Scholar 

  24. Pouillart P, Palangie T, Jouve M et al. (1982) Hormonal therapy in advanced breast cancer. Sequential administration of tamoxifen and medroxyprogesterone acetate. Bull Cancer (Paris) 69: 176–177

    Google Scholar 

  25. Silfverswárd C, Humla S (1980) Estrogen receptor analysis on needle aspirates from human mammary carcinoma. Acta Cytol (Baltimore) 24: 54–57

    Google Scholar 

  26. Silfverswárd C, Skoog L, Humla S, Gustafsson SA, Nordenskjóld B (1980) Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma. Eur J Cancer 16: 59–65

    Article  PubMed  Google Scholar 

  27. Rose C, Mouridsen MT, Palshoff T (1981) Combination of tamoxifen with cytosolic or endocrine therapy. Reviews on Endocrine-Related Cancers (Suppl) Oct: 455–471

    Google Scholar 

  28. Tormey DC, Holland JF, Weinberg V, Weiss R, Falkson G, Glidewell O, Leone L, Perloff M (1981) Five drug-vs-3-drug ± MER postoperative chemotherapy for mammary carcinoma. In: Salmon E, Jones SE (eds) Adjuvant therapy of cancer III. Grune and Stratton, New York, pp 377–384

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section Médicale et Hospitalière, Institut Curie, 26 Rue d’Ulm, 75231, Paris, France

    P. Pouillart, P. M. Martin & H. Magdelénat

Authors
  1. P. Pouillart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. M. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Magdelénat
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute Jules Bordet, Centre des Tumeurs, Service de Medicine, Clinique et Laboratoire de Cancerologie Mammaire, l’Université Libre de Bruxelles, Rue Héger-Bordet 1, 1000, Bruxelles, Belgium

    G. Leclercq , R. Paridaens  & J. C. Heuson ,  & 

  2. Istituto per lo Studio e la Cura dei Tumori, Istituto di Oncologia Sperimentale e Clinica dell’Università, Istituto Nazionale per la Ricerca sul Cancro, Viale Benedetto XV n. 10, 16132, Genova, Italy

    S. Toma

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Pouillart, P., Martin, P.M., Magdelénat, H. (1984). The Place of Hormone Receptors in the Elaboration of a Therapeutic stategy Against Breast Cancer. In: Leclercq, G., Toma, S., Paridaens, R., Heuson, J.C. (eds) Clinical Interest of Steroid Hormone Receptors in Breast Cancer. Recent Results in Cancer Research, vol 91. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82188-2_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82188-2_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82190-5

  • Online ISBN: 978-3-642-82188-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation